Ignite Creation Date:
2024-05-05 @ 9:24 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00874614
Status:
UNKNOWN
Last Update Posted:
2020-02-20
First Post:
2009-04-01
Brief Title:
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant RelapsedRefractory PheochromocytomaParaganglioma
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02
Completion Date Type:
ESTIMATED
First Submit Date:
2009-04-01
First Submit QC Date:
April 1 2009
Study First Post Date:
2009-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2018-03-15
Disp First Submit QC Date:
March 15 2018
Disp First Post Date:
2018-03-19
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-02-20
Last Update Post Date Type:
ACTUAL